Leap Therapeutics Stock Quote LPTX - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

3.25

Bid

3.24

Ask

3.26

Volume

468,801

2.95 Day's Range 3.3339

1.68 52 Week Range 5.00

Market Cap

124.533M

Previous Close

2.99

Open

3.02

Last Trade

500

3.25

Last Trade Time

15:16:04

Financial Volume

$ 1,494,305

VWAP

3.1875

Average Volume (3m)

342,028

Shares Outstanding

38,317,897

Dividend Yield

PE Ratio

-1.50

Earnings Per Share (EPS)

-2.12

Revenue

Net Profit

-81.41M

Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhib... Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1. DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. The company is studying DKN-01 in multiple ongoing clinical trials in patients with esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, or prostate cancer. Its other clinical studies include P100, P102, P204,and P205. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.leaptx.com

Headquarters

Wilmington, Delaware, USA

Founded

Leap Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LPTX. The last closing price for Leap Therapeutics was $2.99. Over the last year, Leap Therapeutics shares have traded in a share price range of $ 1.68 to $ 5.00.

Leap Therapeutics currently has 38,317,897 shares outstanding. The market capitalization of Leap Therapeutics is $114.57 million. Leap Therapeutics has a price to earnings ratio (PE ratio) of -1.50.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.3	10.1694915254	2.95	3.4299	2.7483	593846	3.00249903	CS
4	-0.2	-5.79710144928	3.45	3.6097	2.47	404670	2.8722047	CS
12	0.41	14.4366197183	2.84	4.79	2.2	342028	3.12667884	CS
26	0.9	38.2978723404	2.35	4.79	1.68	221000	2.89719053	CS
52	0.58	21.7228464419	2.67	5	1.68	252869	3.00378186	CS
156	-20.65	-86.4016736402	23.9	34.49	1.235	595085	11.59805092	CS
260	-4.95	-60.3658536585	8.2	41.7	1.235	918926	19.3547041	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
UPCUniverse Pharmaceuticals Inc	$ 2.96 (181.90%)	90.73M
LIFWMSP Recovery Inc	$ 3.939 (147.74%)	14.51M
GXAIGaxos ai Inc	$ 2.5815 (81.80%)	138.57M
SBETSharpLink Gaming Inc	$ 0.91894 (75.37%)	25.45M
SMXSMX Security Matters Public Company	$ 0.5014 (68.59%)	419.48M
ORISOriental Rise Holdings Ltd	$ 3.343 (-94.03%)	22.55M
LICNLichen China Limited	$ 0.435 (-79.48%)	172.47M
MYNAMynaric AG	$ 0.49 (-65.25%)	3.16M
CEROCERo Therapeutics Holdings Inc	$ 0.1149 (-40.00%)	31.78M
BJDXBluejay Diagnostics Inc	$ 4.06 (-34.52%)	381.96k
SMXSMX Security Matters Public Company	$ 0.5014 (68.59%)	419.48M
SOUNSoundHound AI Inc	$ 14.73 (10.50%)	190.13M
LICNLichen China Limited	$ 0.435 (-79.48%)	172.47M
SVMHSRIVARU Holding Ltd	$ 0.0302 (-13.71%)	140.16M
NVDANVIDIA Corporation	$ 141.975 (-2.13%)	139.92M